Treponema Pallidum Hemagglutination Assay (TPHA) Test: A Comprehensive Analysis of Syphilis Infection
The Treponema Pallidum Hemagglutination Assay (TPHA) is a qualitative and semi-quantitative test used for the detection of antibodies to Treponema pallidum in human serum or plasma
. This test is primarily prescribed by doctors to detect syphilis, a sexually transmitted infection caused by the bacteria Treponema pallidum
Procedure: The TPHA test involves sensitizing red blood cells with T. pallidum fragments and exposing them to a serum sample that may contain syphilis antibodies. If the antibodies are present, the red blood cells will aggregate on the surface of the test card
Sample Type: A blood sample, typically drawn by inserting a needle into a vein in your arm, is required for this test
Purpose: The TPHA test is used to detect the presence of syphilis antibodies in the bloodstream, which can indicate an infection at various stages
The TPHA test is used for:
Diagnosing and monitoring syphilis infections at different stages.
Confirming the presence of syphilis when other tests, such as the Venereal Disease Research Laboratory (VDRL) test, show indirect evidence of the infection
Assessing the effectiveness of treatment plans for syphilis infections.
To ensure accurate results, follow these guidelines:
Schedule an appointment with us to discuss your need for the TPHA test.
Fasting is not required for this test, but it is recommended to avoid eating or drinking for 8-12 hours before the test.
If you have any known medical conditions or are taking medications, inform your doctor, as some drugs can affect the test results.
Choose our Treponema Pallidum Hemagglutination Assay (TPHA) Test for a comprehensive analysis of syphilis infection and early detection of potential cases